Detalhe da pesquisa
1.
Real-life effectiveness 1 year after switching to avalglucosidase alfa in late-onset Pompe disease patients worsening on alglucosidase alfa therapy: A French cohort study.
Eur J Neurol
; 31(7): e16292, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587143
2.
Successful treatment of JAK1-associated inflammatory disease.
J Allergy Clin Immunol
; 152(4): 972-983, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37343845
3.
Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme®) in 12 patients with advanced late-onset Pompe disease.
Mol Genet Metab
; 122(1-2): 80-85, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28648663
4.
Balance control impairments in Fabry disease.
Front Neurol
; 13: 856946, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36247762
5.
Leukocyte differential for acute abdominal pain in adults.
Lab Hematol
; 17(1): 1-5, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21421538
6.
Systemic capillary leak syndrome and autoimmune diseases: A case series.
Semin Arthritis Rheum
; 46(4): 509-512, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27637319